Hunter Cherwek, MD, of Orbis discusses summit commitments, eye care workforce training, and AI in low-resource settings.
Related to this article
Clinical Forum cases examine symptoms, progression, and treatment response.
Uday Devgan, MD, FACS, Jordana G. Fein, MD, MS, and Carl D. Regillo, MD, FASRS, point to IOL education, emerging retina therapies, and treatment burden.
Murtaza K. Adam, MD, reviews 3 patient cases to explore referral patterns, neovascularization after treatment, and barriers to care.
Andrew G. Lee, MD, and Drew Carey, MD, break down the visual safety of flow-diverting stents for carotid-ophthalmic aneurysms.
Christopher J. Rapuano, MD, discusses emergency eye care access, retina advances and responsible AI use in ophthalmology.
A simple stool test may reveal hidden bowel disease in patients whose only symptoms are in their eyes.
Jordana G. Fein, MD, MS, points to agent selection, payer requirements, and real-world treatment response across 3 retina cases.
Advertisement
Advertisement
Trending on Eye Care Network - Ophthalmology Times
1
FDA approves ranibizumab biosimilar Lucamzi for wet AMD
2
October 2026 retina recap: Duravyu stumbles, DAYBREAK delivers, and optogenetics takes the Nobel
3
Eyes on October 2026: AAO and EURETINA highlights, a trio of FDA approvals, and optogenetics takes the spotlight
4
Christopher Starr, MD, FACS, on preventing the unhappy 20/20 patient
5